Copper-aspirin complex inhibits cyclooxygenase-2 more selectively than aspirin

Yakugaku Zasshi

Volumn 127, Issue 11, 2007, Pages 1869-1875

  Yun, Yu ^a   Chen, Peng ^a   Zheng, Chun Lan ^a   Yang, Yong ^a   Duan, Wei Gang ^b   Wang, Lei ^a   He, Bo ^a   Ma, Jia Qing ^a   Wang, Dian Hua ^a   Shen, Zhi Qiang ^a  

^a KUNMING MEDICAL UNIVERSITY   (China)

^b YUNNAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

6 keto prostaglandin F1 ; Aspirin; Copper aspirin complex; Prostaglandin E2

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ACETYLSALICYLATE COPPER; ACETYLSALICYLIC ACID; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; PROSTAGLANDIN E2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL LINE; CONTROLLED STUDY; DRUG INHIBITION; DRUG SELECTIVITY; ENDOTHELIUM CELL; ENZYME INHIBITION; HUMAN; HUMAN CELL; IC 50; INHIBITION KINETICS; MACROPHAGE; MOUSE; NONHUMAN; RADIOIMMUNOASSAY; RAT; UMBILICAL VEIN;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CELLS, CULTURED; COPPER; CYCLOOXYGENASE 2 INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MICE; MICE, INBRED ICR;

EID: 35948948345     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.1869     Document Type: Article

References (32)

1. Alich A. A., Wittmers L. E., J. Pharm. Sci., 69, 725-727 (1980).
2. Williams D. A., Walz D. T., Foye W. O., J. Pharm. Sci., 65, 126-128 (1976).
3. Chohan Z. H., Iqbal M. S., Iqbal H. S., Scozzafava A., Supuran C. T., J. Enzyme Inhib. Med. Chem., 17, 87-91 (2002).
4. Franco L., Velo G. P., Prostaglandins, 51, 331-338 (1996).
5. Shen Z. Q., Lei W. Y., Li L., Chen Z. H., Liu W. P., Inflammopharmacology, 6, 357-363 (1998).
6. Li L., Wu L. O., Liu W. P., Xiong H. Z., Chen Z. H., Yang Y. K., Kunming Yixueyuan Xuebao (Chinese), 17, 1-3 (1996).
7. Franco L., Doria D., Pharmacol. Res., 36, 395-399 (1997).
8. Lewis A. J., Agents Actions, 8, 244-250 (1978).
9. Wu K. K., Semin. Vasc. Med., 3, 107-112 (2003).
10. Salem H., Dunn B. J., Loux J. J., Ann. Ophthalmol., 7, 819-824 (1975).
11. Chan C. C., Rodger I. W., Adv. Exp. Med. Biol., 407, 157-161 (1997).
12. Taketo M. M., J. Natl. Cancer Inst., 90, 1529-1536 (1998).
13. Taketo M. M., J. Natl. Cancer Inst., 90, 1609-1620 (1998).
14. Chandrasekharan N. V., Hu D., Roos K. L. T., PNAS, 99, 13926-13931 (2002).
15. Wu S., Duan S., Zhao S., Cai Y., Chen P., Fang X., Respir. Res., 6, 27 (2005).
16. Chang M. S., Chen B. C., Yu M. T., Sheu J. R., Chen T. F., Lin C. H., Cell Signal, 17, 299-310 (2005).
17. Jung Y. J., Isaacs J. S., Lee S., Trepel J., Neckers L., FASEB J., 17, 2115-2117 (2003).
18. Mitchell J. A., Akarasereenont P., Thiemermann C., Flower R. J., Vane J. R., Proc. Natl. Acad. Sci. USA, 90, 11693-11697 (1993).
19. Williams G. W., Curr. Pain Headache Rep., 9, 377-389 (2005).
20. Borer J. S., Simon L. S., Arthritis Res. Ther., 7 Suppl 4, S14-22 (2005).
21. Cronstein B. N., Cleve Clin. J. Med., 69 Suppl 1, SI13-19 (2002).
22. Johnson J. L., Wimsatt J., Buckel S. D., Dyer R. D., Maddipati K. R., Arch. Biochem. Biophys., 324, 26-34 (1995).
23. Ferrari R. P., Paradisi L., Torrielli M., Anticancer Res., 9, 771-773 (1989).
24. Chen C. H., Lin H., Hsu Y. H., Sue Y. M., Cheng T. H., Chan P., Chen T. H., Eur. J. Pharmacol., 529, 8-15 (2006).
25. Hu Y. F., Cheng G. F., Acta Pharm. Sin. (Chinese), 35, 343-346 (2000).
26. Shyue S. K., Tsai M. J., Liou J. Y., Willerson J. T., Wu K. K., Circulation, 103, 2090-2095 (2001).
27. Yamada T., Komoto J., Watanabe K., Ohmiya Y., Takusagawa F., J. Mol. Biol., 348, 1163-1176 (2005).
28. Yao J. C., Duan W. G., Yun Y., Liu de Q., Yan M., Jiang Z. Z., Zhang L. Y., Yakugaku Zasshi, 127, 527-532 (2007).
29. Duan W., Zhang L., Prostaglandins Leukot. Essent. Fatty Acids, 74, 317-321 (2006).
30. Barnett J., Chow J., Ives D., Chiou M., Mackenzie R., Osen E., Nguyen B., Tsing S., Bach C., Freire J., Biochim. Biophys. Acta, 1209, 130-139 (1994).
31. Hawkey C. J., Lancet, 353, 307-314 (1999).
32. Smith W. L., DeWitt D. L., Kraemer S. A., Andrews M. J., Hla T., Maciag T., Shimokawa T., Adv. Prostaglandin Thromboxane Leukot. Res., 20, 14-21 (1990).